Anti-Arrhythmic Effects of Exercise After an Implantable Defibrillator (ICD)

植入式除颤器 (ICD) 后运动的抗心律失常作用

• 批准号: 7426489
• 负责人: CYNTHIA M DOUGHERTY
• 金额: $ 73.7万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7426489
• 关键词: Aerobic; Aerobic Exercise; Affect; Age; Age Factors; Anti-Arrhythmia Agents; Anxiety; Arrhythmia; Autonomic nervous system; Belief; Cardiac; Cardiopulmonary; Cardiovascular Diseases; Cardiovascular system; Caring; Cessation of life; Clinical Trials Design; Defibrillators; Development; Distress; EFRAC; Event; Exercise; Exercise stress test; Future; Gender; Goals; Health; Health Personnel; Heart Arrest; Heart Diseases; Heart Rate; Home environment; Hour; Implant; Implantable Defibrillators; Individual; Inflammation; Interleukin-6; Intervention; K-Series Research Career Programs; Life; Maintenance; Mediating; Mental Depression; Modeling; Monitor; Morbidity - disease rate; Numbers; Outcome; Outcome Study; Parasympathetic Nervous System; Patients; Personal Satisfaction; Persons; Pilot Projects; Population; Populations at Risk; Predisposition; Quality of life; Randomized; Randomized Clinical Trials; Randomized Controlled Clinical Trials; Recurrence; Regulation; Research; Research Personnel; Resuscitation; Risk; Role; SF-36; Sampling; Secondary Prevention; Shock; Symptoms; Telephone; Testing; Theoretical model; Time; Training; Tumor Necrosis Factor-alpha; Ventricular; Ventricular Arrhythmia; Ventricular Fibrillation; Ventricular Tachycardia; Walking; Week; conditioning; cost; cysteine rich protein; design; health related quality of life; human TNF protein; improved; innovation; mortality; prescription document; prescription procedure; prevent; programs; psychological distress; psychosocial; treatment effect

DESCRIPTION (provided by applicant): The long term goal of this research is to design exercise interventions to reduce major adverse cardiac events (cardiac morbidity and mortality) and costs of care in individuals who have ventricular arrhythmias with an implantable cardioverter defibrillator (ICD). The goal of this study is to determine if an aerobic exercise intervention in addition to usual care, will significantly improve cardiopulmonary function, cardiac autonomic activity, and quality of life while reducing ventricular arrhythmias, inflammation, and psychological distress in patients with ventricular arrhythmias who have an ICD for the secondary prevention of sudden cardiac arrest (SCA). Aerobic exercise is known to increase parasympathetic cardiovascular regulation and reduce cardiac mortality. In our pilot study, we demonstrated that aerobic conditioning, strenuous enough to improve cardiopulmonary function, could be safely implemented in this population. The specific aims of this study are to test the hypotheses that: 1) aerobic exercise (5 hours/week for 8 weeks home walking at 60- 80% of peak V02 HR followed by 16 weeks of exercise maintenance) compared to usual care alone will increase cardiopulmonary function (peak V02), 2) aerobic exercise will increase cardiac autonomic activity (heart rate variability (HRV) and health related quality of life (SF-36 and Patient Concerns), while reducing ventricular arrhythmias (ICD shocks, VF/VT), psychological distress (anxiety and depression), and inflammation (hsCRP, BNP, TNF-alpha, IL-6); and 3) aerobic exercise will mediate effects on outcomes through improvement in cardiopulmonary function. Using a randomized clinical trial format, an aerobic exercise program in addition to usual care will be tested against usual care alone. The exercise intervention is designed to be conducted at home after a cardiopulmonary exercise test, using careful telephone and Polar Heart rate monitoring. The primary analysis for treatment effect is improvement in cardiopulmonary function at the end of 8 weeks. Longitudinal effects of the program will be assessed at 6 months. Secondarily, describing the effects of aerobic exercise on other outcomes will be determined. Study findings are expected to be useful clinically in making exercise prescriptions after an ICD and to be generalizable to populations at risk for recurrent SCA who have an ICD.

描述（由申请人提供）：本研究的长期目标是设计运动干预措施，以减少植入式心律转复除颤器（ICD）的室性心律失常患者的主要不良心脏事件（心脏病发病率和死亡率）和护理费用。本研究的目的是确定除常规护理外，有氧运动干预是否会显著改善心肺功能、心脏自主活动和生活质量，同时减少室性心律失常患者的室性心律失常、炎症和心理困扰，这些患者已植入ICD用于心脏骤停（SCA）的二级预防。众所周知，有氧运动可以增加副交感神经对心血管的调节，降低心脏病死亡率。在我们的初步研究中，我们证明了有氧训练，艰苦足以改善心肺功能，可以安全地实施在这一人群中。本研究的具体目的是检验以下假设：1）有氧运动（5小时/周，持续8周，以峰值V02 HR的60- 80%在家步行，随后进行16周的运动维持）与单独的常规护理相比将增加心肺功能（峰值V02），2）有氧运动会增加心脏自主活动（心率变异性（HRV）和健康相关的生活质量（SF-36和患者问题），同时减少室性心律失常（ICD电击，VF/VT），心理困扰（焦虑和抑郁）和炎症（hsCRP，BNP，TNF-α，IL-6）;和3）有氧运动将通过改善心肺功能介导对结果的影响。采用随机临床试验的形式，除了常规护理之外，还将对常规护理进行有氧运动计划测试。运动干预设计为在心肺运动测试后在家中进行，使用仔细的电话和Polar心率监测。治疗效果的主要分析是8周末心肺功能的改善。该计划的纵向效果将在6个月时进行评估。其次，描述有氧运动对其他结果的影响将被确定。研究结果有望在临床上对ICD术后的运动处方制定有所帮助，并可推广到有ICD复发SCA风险的人群。